II. Indications
- See Hyperlipidemia Management for formal criteria
- See Statin
- Hyperlipidemia
- Primary of vascular disease progression (e.g. CAD, CVA, DM, CKD, PAD)
III. Contraindications
- See Statin
- Drug Interactions
- Pregnancy (Teratogen)
- Acute Liver Failure or decompensated Cirrhosis
IV. Mechanism
- See Statin
V. Efficacy
- See Statin
- Rosuvastatin 5 mg lowers LDL 45%
- Rosuvastatin 10 mg lowers LDL: 46 to 52%
- Rosuvastatin 20 mg lowers LDL 50 to 55%
- Rosuvastatin 40 mg lowers LDL: 55 to 63%
VI. Adverse Effects
- See Statin
- See Statin-Induced Myopathy
VII. Safety
- Pregnancy Category X
- Contraindicated in Lactation
VIII. Pharmacokinetics
- See Statin
- Undergoes first pass metabolism as with most Statins (except Pravastatin)
- 
                          Protein binding- As with most Statins (except Pravastatin), Rosuvastatin is 90% Protein bound
 
- 
                          Cytochrome P450 Metabolism- Rosuvastatin, like Pravastatin, is NOT metabolized by CYP3A4 isoenzyme
 
IX. Dosing: Adult
- Specific LDL and HDL targets have been replaced with high-intensity Statin if 10 year Cardiovascular Risk >20%
- High intensity Statin (age <75 years with 10 year Cardiovascular Risk >20%)- Rosuvastatin 20-40 mg orally daily
 
- Low intensity Statin (age >75 years, or Statin intolerant)- Rosuvastatin 25-10 mg orally daily
 
- Indications to start at lower dose (5 mg)- Asians- Higher drug levels leads to higher toxicity risk
 
- Renal Insufficiency (max 10 mg if CrCl < 30 ml/min)
- Hypothyroidism (uncontrolled)
- Age over 65 years
- Cyclosporine use (max dose 5 mg daily)
- Concurrent Gemfibrozil (max dose 10 mg daily)
 
- Asians
X. Dosing: Child
- Heterozygous Familial Hyperlipidemia- Age 8 to 9 years old- Rosuvastatin 5 to 10 mg orally daily
 
- Age 10 years and older- Rosuvastatin 5 to 20 mg orally daily
 
 
- Age 8 to 9 years old
- Homozygous Familial Hyperlipidemia- Age 7 to 17 years old- Rosuvastatin 20 mg orally daily
 
 
- Age 7 to 17 years old
XI. Monitoring
XII. Drug Interactions (See Contraindications above)
- See Statin
- 
                          CYP3A4/organic anion transporting polypeptide inhibitors- Cyclosporine (10-20 fold increase in Statin serum levels)- Avoid with Rosuvastatin over 5 mg daily
 
- Macrolides (Erythromycin,  Clarithromycin - 6-10 fold increase in Statin serum levels)- Does not appear to significantly affect Rosuvastatin
- Azithromycin appears to be safe with Statins
 
- Protease inibitors (Atazanavir, Ritonavir, Lopinavir/Ritonavir)- Avoid with Rosuvastatin over 10 mg daily
 
 
- Cyclosporine (10-20 fold increase in Statin serum levels)
- 
                          CYP3A4/CYP2C9 Inhibitor- Warfarin (Increased INR and bleeding risk)- Among the highest risk agents with Rosuvastatin
 
 
- Warfarin (Increased INR and bleeding risk)
- 
                          CYP2C9, CYP2C19/oragnic anion transporting polypeptide inhibitors- Gemfibrozil (2-3 fold increase in Statin serum levels, >13 fold increase in Rhabdomyolysis risk)- Avoid with Rosuvastatin over 10 mg daily
 
 
- Gemfibrozil (2-3 fold increase in Statin serum levels, >13 fold increase in Rhabdomyolysis risk)
- Other interactions- Mibefradil (Posicor)
- Niacin
- Alcohol- Increases risk of liver enzyme elevations
 
 
XIII. Resources
- See Statin
- Rosuvastatin (DailyMed)
XIV. References
- (2017) Presc Lett 24(11): 62
- (2012) Presc Lett 19(5): 25
- (2012) Presc Lett, Characteristics of Various Statins, #280502
- Carpenter (2019) Am Fam Physician 99(9):558-64 [PubMed]
- Chong (2001) Am J Med 111:390-400 [PubMed]
- Crouch (2001) Am Fam Physician 63(2):309-20 [PubMed]
- Gillett (2011) Am Fam Physician 83(6): 711-6 [PubMed]
- Jones (1998) Am J Cardiol 81:582-7 [PubMed]
- Sasaki (1998) Clin Ther 20:539-48 [PubMed]
Images: Related links to external sites (from Bing)
Related Studies
| rosuvastatin (on 12/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| ROSUVASTATIN CALCIUM 10 MG TAB | Generic | $0.05 each | 
| ROSUVASTATIN CALCIUM 20 MG TAB | Generic | $0.08 each | 
| ROSUVASTATIN CALCIUM 40 MG TAB | Generic | $0.12 each | 
| ROSUVASTATIN CALCIUM 5 MG TAB | Generic | $0.05 each | 
| crestor (on 9/21/2022 at Medicaid.Gov Survey of pharmacy drug pricing) | ||
| CRESTOR 10 MG TABLET | Generic | $0.05 each | 
| CRESTOR 20 MG TABLET | Generic | $0.08 each | 
| CRESTOR 40 MG TABLET | Generic | $0.12 each | 
| CRESTOR 5 MG TABLET | Generic | $0.05 each | 
